| 5.57 -0.36 (-6.07%) | 01-20 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | ||||
| Targets | 6-month : | 6.68 |
1-year : | 7.24 |
| Resists | First : | 5.72 |
Second : | 6.19 |
| Pivot price | 5.59 |
|||
| Supports | First : | 4.96 |
Second : | 4.12 |
| MAs | MA(5) : | 5.69 |
MA(20) : | 5.65 |
| MA(100) : | 6.58 |
MA(250) : | 7.45 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 57.4 |
D(3) : | 53.8 |
| RSI | RSI(14): 47 |
|||
| 52-week | High : | 22.42 | Low : | 3.01 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SSII ] has closed above bottom band by 46.2%. Bollinger Bands are 63.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 6 - 6.03 | 6.03 - 6.06 |
| Low: | 5.48 - 5.51 | 5.51 - 5.55 |
| Close: | 5.51 - 5.56 | 5.56 - 5.61 |
SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.
Sat, 17 Jan 2026
Assessing SS Innovations International (SSII) Valuation After Record 2025 Guidance And Expanding Surgical Robot Installations - Sahm
Thu, 15 Jan 2026
Surging 2025 Revenue and New Leadership Could Be A Game Changer For SS Innovations International (SSII) - Sahm
Wed, 14 Jan 2026
Surging 2025 Revenue and New Leadership Could Be A Game Changer For SS Innovations International (SSII) - simplywall.st
Tue, 13 Jan 2026
SS Innovations Posts Preliminary Full-Year 2025 Revenue Growth Of 108% - Nasdaq
Tue, 13 Jan 2026
SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025 - Yahoo Finance
Fri, 09 Jan 2026
A Look At SS Innovations International (SSII) Valuation After New 5 Mm Tools And Leadership Appointment - Sahm
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 194 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 83 (%) |
| Held by Institutions | 0.2 (%) |
| Shares Short | 136 (K) |
| Shares Short P.Month | 115 (K) |
| EPS | -0.06 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.2 |
| Profit Margin | -32.2 % |
| Operating Margin | -14.4 % |
| Return on Assets (ttm) | -10.7 % |
| Return on Equity (ttm) | -43.5 % |
| Qtrly Rev. Growth | 192.5 % |
| Gross Profit (p.s.) | 0.08 |
| Sales Per Share | 0.18 |
| EBITDA (p.s.) | -0.05 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -20 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | -92.84 |
| PEG Ratio | 0 |
| Price to Book value | 27.85 |
| Price to Sales | 29.89 |
| Price to Cash Flow | -53.16 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |